123 related articles for article (PubMed ID: 18040152)
21. Antigen-specific T-cell induction by vaccination with a recombinant Sendai virus vector even in the presence of vector-specific neutralizing antibodies in rhesus macaques.
Moriya C; Horiba S; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Matano T
Biochem Biophys Res Commun; 2008 Jul; 371(4):850-4. PubMed ID: 18466766
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector.
Wiegand M; Gori-Savellini G; Martorelli B; Bossow S; Neubert WJ; Cusi MG
Vaccine; 2013 Aug; 31(37):3888-93. PubMed ID: 23831325
[TBL] [Abstract][Full Text] [Related]
23. A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo.
Ferrari S; Griesenbach U; Shiraki-Iida T; Shu T; Hironaka T; Hou X; Williams J; Zhu J; Jeffery PK; Geddes DM; Hasegawa M; Alton EW
Gene Ther; 2004 Nov; 11(22):1659-64. PubMed ID: 15284837
[TBL] [Abstract][Full Text] [Related]
24. Recombinant sendai virus-mediated gene transfer to mouse pancreatic stem cells.
Oishi K; Noguchi H; Yukawa H; Inoue M; Takagi S; Iwata H; Hasegawa M; Hayashi S
Cell Transplant; 2009; 18(5):573-80. PubMed ID: 19775519
[TBL] [Abstract][Full Text] [Related]
25. Cytoplasmic RNA vector derived from nontransmissible Sendai virus. Production and use.
Iida A; Hasegawa M
Methods Mol Med; 2002; 69():361-70. PubMed ID: 11987789
[No Abstract] [Full Text] [Related]
26. Newly-developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope-related genes.
Murakami Y; Ikeda Y; Yonemitsu Y; Tanaka S; Kondo H; Okano S; Kohno R; Miyazaki M; Inoue M; Hasegawa M; Ishibashi T; Sueishi K
J Gene Med; 2008 Feb; 10(2):165-76. PubMed ID: 18074401
[TBL] [Abstract][Full Text] [Related]
27. Persistent and stable gene expression by a cytoplasmic RNA replicon based on a noncytopathic variant Sendai virus.
Nishimura K; Segawa H; Goto T; Morishita M; Masago A; Takahashi H; Ohmiya Y; Sakaguchi T; Asada M; Imamura T; Shimotono K; Takayama K; Yoshida T; Nakanishi M
J Biol Chem; 2007 Sep; 282(37):27383-27391. PubMed ID: 17623660
[TBL] [Abstract][Full Text] [Related]
28. An efficient and versatile mammalian viral vector system for major histocompatibility complex class I/peptide complexes.
Kawana-Tachikawa A; Tomizawa M; Nunoya J; Shioda T; Kato A; Nakayama EE; Nakamura T; Nagai Y; Iwamoto A
J Virol; 2002 Dec; 76(23):11982-8. PubMed ID: 12414940
[TBL] [Abstract][Full Text] [Related]
29. A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading.
Inoue M; Tokusumi Y; Ban H; Kanaya T; Shirakura M; Tokusumi T; Hirata T; Nagai Y; Iida A; Hasegawa M
J Virol; 2003 Jun; 77(11):6419-29. PubMed ID: 12743299
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of the rescue efficiency of Sendai virus minigenome mediated by CMV and T7 promoter].
Wei GC; Tian WH; Wang G; Liu YF; Yu CJ; Dong XY; Ling H; Wu XB
Bing Du Xue Bao; 2012 May; 28(3):237-45. PubMed ID: 22764526
[TBL] [Abstract][Full Text] [Related]
31. Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.
Kaneda Y
Expert Opin Drug Deliv; 2008 Feb; 5(2):221-33. PubMed ID: 18248320
[TBL] [Abstract][Full Text] [Related]
32. Severe impairment of dendritic cell allostimulatory activity by Sendai virus vectors is overcome by matrix protein gene deletion.
Armeanu S; Bitzer M; Smirnow I; Bossow S; Appel S; Ungerechts G; Bernloehr C; Neubert WJ; Lauer UM; Brossart P
J Immunol; 2005 Oct; 175(8):4971-80. PubMed ID: 16210599
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of choroidal neovascularization via brief subretinal exposure to a newly developed lentiviral vector pseudotyped with Sendai viral envelope proteins.
Murakami Y; Ikeda Y; Yonemitsu Y; Miyazaki M; Inoue M; Hasegawa M; Sueishi K; Ishibashi T
Hum Gene Ther; 2010 Feb; 21(2):199-209. PubMed ID: 19778186
[TBL] [Abstract][Full Text] [Related]
34. Expression and maturation of Sendai virus vector-derived CFTR protein: functional and biochemical evidence using a GFP-CFTR fusion protein.
Ban H; Inoue M; Griesenbach U; Munkonge F; Chan M; Iida A; Alton EW; Hasegawa M
Gene Ther; 2007 Dec; 14(24):1688-94. PubMed ID: 17898794
[TBL] [Abstract][Full Text] [Related]
35. Sendai virus transgene in a novel gene therapy for laryngotracheal disease.
Mizokami D; Araki K; Tanaka N; Suzuki H; Tomifuji M; Yamashita T; Inoue M; Hasegawa M; Shiotani A
Laryngoscope; 2013 Jul; 123(7):1717-24. PubMed ID: 23666749
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity of repeated Sendai viral vector vaccination in macaques.
Kurihara K; Takahara Y; Nomura T; Ishii H; Iwamoto N; Takahashi N; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Moriya C; Matano T
Microbes Infect; 2012 Nov; 14(13):1169-76. PubMed ID: 22884717
[TBL] [Abstract][Full Text] [Related]
37. In vivo repopulation of cytoplasmically gene transferred hematopoietic cells by temperature-sensitive mutant of recombinant Sendai viral vector.
Yoshida K; Yonemitsu Y; Tanaka S; Yoshida S; Shibata S; Kondo H; Okano S; Ishikawa F; Akashi K; Inoue M; Hasegawa M; Sueishi K
Biochem Biophys Res Commun; 2007 Sep; 361(3):811-6. PubMed ID: 17678616
[TBL] [Abstract][Full Text] [Related]
38. Negative-strand RNA viral vectors: intravenous application of Sendai virus vectors for the systemic delivery of therapeutic genes.
Bitzer M; Ungerechts G; Bossow S; Graepler F; Sedlmeier R; Armeanu S; Bernloehr C; Spiegel M; Gross CD; Gregor M; Neubert WJ; Lauer UM
Mol Ther; 2003 Feb; 7(2):210-7. PubMed ID: 12597909
[TBL] [Abstract][Full Text] [Related]
39. Sendai virus-mediated gene transfer of the c-myc suppressor far-upstream element-binding protein-interacting repressor suppresses head and neck cancer.
Tanaka N; Araki K; Mizokami D; Miyagawa Y; Yamashita T; Tomifuji M; Ueda Y; Inoue M; Matsushita K; Nomura F; Shimada H; Shiotani A
Gene Ther; 2015 Apr; 22(4):297-304. PubMed ID: 25588744
[TBL] [Abstract][Full Text] [Related]
40. Validation of recombinant Sendai virus in a non-natural host model.
Griesenbach U; McLachlan G; Owaki T; Somerton L; Shu T; Baker A; Tennant P; Gordon C; Vrettou C; Baker E; Collie DD; Hasegawa M; Alton EW
Gene Ther; 2011 Feb; 18(2):182-8. PubMed ID: 20962870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
